BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
35.11
-1.29 (-3.54%)
At close: Mar 28, 2025, 4:00 PM
34.91
-0.20 (-0.57%)
After-hours: Mar 28, 2025, 7:16 PM EDT
BridgeBio Pharma Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$52.90
Upside
+50.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $44 → $50 | Buy | Maintains | $44 → $50 | +42.41% | Mar 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $49 | Strong Buy | Maintains | $45 → $49 | +39.56% | Feb 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $95 | Buy | Reiterates | $95 | +170.58% | Feb 21, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $49 → $52 | Buy | Maintains | $49 → $52 | +48.11% | Feb 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +39.56% | Feb 13, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $48 → $49 | Buy | Maintains | $48 → $49 | +39.56% | Feb 12, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +42.41% | Dec 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $49 | Strong Buy | Reiterates | $49 | +39.56% | Dec 16, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +36.71% | Nov 25, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +28.17% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $49 | Strong Buy | Maintains | $43 → $49 | +39.56% | Nov 25, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $44 → $45 | Buy | Maintains | $44 → $45 | +28.17% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +22.47% | Oct 25, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $47 → $46 | Buy | Maintains | $47 → $46 | +31.02% | Oct 17, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $44 | Buy | Initiates | $44 | +25.32% | Oct 16, 2024 |
| Oppenheimer | Oppenheimer | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.